Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Enters Definitive Agreement to Acquire Canna Farms Ltd.

Globally licensed cannabis company ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced its entrance into a definitive agreement to acquire 100% of the issued and outstanding share capital of Canna Farms Limited, a premium cannabis company in British Columbia. The acquisition enables the two complementary businesses to leverage their strengths prior to the opening of the Canadian adult-use market in the fall. The transaction value of approximately $133 million will be comprised of $22 million in cash and 92.5 million ABcann shares. The shares will be released from escrow in six month increments over a total of 30 months. Upon completion of the transaction, Canna Farms’ co-founders, Daniel Laflamme and Raymond Laflamme, will each own 16.1% of ABcann’s outstanding shares. They will serve the combined company as President, Canna Farms and Senior Vice President, Facilities and Engineering, respectively. Daniel Laflamme will also be appointed to ABcann’s Board of Directors. Closing of the transaction is anticipated in August 2018, subject to customary closing conditions, including the conditional approval of the TSXV and applicable regulatory approvals. “This is a transformational acquisition, and key benefits include increased production capacity, an expanded product offering, operational efficiencies, and a more robust platform to accelerate our growth,” ABcann CEO Barry Fishman stated in the news release. “We will maximize operational and financial synergies, so that the combined company will be greater than the sum of its parts.”

To view the full press release, visit

About ABcann Global Corp.

ABcann is recognized for high-quality, trusted products and services. It holds production and sales licenses from Health Canada, and its flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centered on its specially designed, environmentally-controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products. ABcann is expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, such as Germany, Australia and Israel. For more information, visit the company’s website at

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published:

This entry was posted in MissionIRNewsBreaks, VIVO Cannabis Inc. VVCIF. Bookmark the permalink.

Comments are closed.